Drug Safety

Acknowledgement
pp. 1083-1085(3)
Author: Adis International Limited,

Biotherapeutics in the Era of Biosimilars: What Really Matters is Patient Safety
pp. 1087-1092(6)
Author: Declerck, Paul J.

Cardiac Repolarisation and Drug Regulation: Assessing Cardiac Safety 10 Years after the CPMP Guidance
pp. 1093-1110(18)
Author: Shah, Rashmi R.

Interventions to Reduce Dosing Errors in Children: A Systematic Review of the Literature
pp. 1111-1125(15)
Authors: Conroy, Sharon; Sweis, Dimah; Planner, Claire; Yeung, Vincent; Collier, Jacqueline; Haines, Linda; Wong, Ian C.K.

Bodyweight Changes Associated with Antihyperglycaemic Agents in Type 2 Diabetes Mellitus
pp. 1127-1142(16)
Authors: Hermansen, Kjeld; Mortensen, Lene S.

Detection of Spironolactone-Associated Hyperkalaemia Following the Randomized Aldactone Evaluation Study (RALES)
pp. 1143-1149(7)
Authors: Hauben, Manfred; Reich, Lester; Gerrits, Charles M.; Madigan, David

Comparative Safety of Long-Acting Inhaled Bronchodilators: A Cohort Study Using the UK THIN Primary Care Database
pp. 1151-1160(10)
Authors: Jara, Michele; Lanes, Stephan F.; Charles Wentworth III,; May, Corey; Kesten, Steven

Analysis of Severe Hepatic Events Associated with Nevirapine-Containing Regimens: CD4+ T-Cell Count and Gender in Hepatitis C Seropositive and Seronegative Patients
pp. 1161-1169(9)
Authors: Torti, Carlo; Costarelli, Silvia; Annalisa De Silvestri,; Quiros-Roldan, Eugenia; Lapadula, Giuseppe; Cologni, Giuliana; Paraninfo, Giuseppe; Castelnuovo, Filippo; Puoti, Massimo; Carosi, Giampiero

Age- and Gender-Specific Incidence of Hospitalisation for Digoxin Intoxication
pp. 1171-1173(3)
Authors: Schmiedl, Sven; Szymanski, Jacek; Rottenkolber, Marietta; Hasford, Joerg; Thürmann, Petra A.

The Authors' Reply
pp. 1173-1174(2)
Authors: Aarnoudse, Adrianus L.H.J.; Dieleman, Jeanne P.; Stricker, Bruno H.Ch.